These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 8750576

  • 1. Decreased secretion of gonadotropins in a patient with Graves' disease.
    Hakamata M, Itoh M, Sudo Y, Katada E, Miyata N.
    Exp Clin Endocrinol Diabetes; 1996; 104(1):85-8. PubMed ID: 8750576
    [Abstract] [Full Text] [Related]

  • 2. [Stimulation of endogenous TSH secretion and endocrine orbitopathy].
    Wuttke H, Schlieter D.
    Med Klin; 1980 Aug 29; 75(18):658-62. PubMed ID: 6158667
    [Abstract] [Full Text] [Related]

  • 3. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
    Wu G, Jie Y, Situ Y.
    Zhonghua Yi Xue Za Zhi; 2001 Mar 10; 81(5):274-5. PubMed ID: 11798886
    [Abstract] [Full Text] [Related]

  • 4. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.
    Clin Endocrinol (Oxf); 2004 Jun 10; 60(6):676-81. PubMed ID: 15163329
    [Abstract] [Full Text] [Related]

  • 5. Functional relationships of the hypothalamic-pituitary-testicular system in Graves' disease.
    Földes J, Bános C, Fehér T, Bodrogi L, Szalay F, Borvendég J, Csillag J, Takó J.
    Acta Med Acad Sci Hung; 1982 Jun 10; 39(3-4):109-16. PubMed ID: 6821015
    [Abstract] [Full Text] [Related]

  • 6. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC, Ingbar SH.
    J Clin Invest; 1979 Nov 10; 64(5):1429-36. PubMed ID: 91625
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM, Lima N, Knobel M, Cavaliere H, Medeiros-Neto G.
    Eur J Med; 1993 Feb 10; 2(2):70-4. PubMed ID: 8258020
    [Abstract] [Full Text] [Related]

  • 8. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F, González-Ortiz M, Durón H, Sánchez C.
    Rev Invest Clin; 2002 Feb 10; 54(4):307-10. PubMed ID: 12415954
    [Abstract] [Full Text] [Related]

  • 9. Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery.
    Slyper AH, Wyatt D, Boudreau C.
    J Pediatr Endocrinol Metab; 2005 Jun 10; 18(6):597-602. PubMed ID: 16042328
    [Abstract] [Full Text] [Related]

  • 10. Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13.
    Komiya I, Yamada T, Sato A, Kouki T, Nishimori T, Takasu N.
    J Clin Endocrinol Metab; 2001 Aug 10; 86(8):3540-4. PubMed ID: 11502776
    [Abstract] [Full Text] [Related]

  • 11. Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease.
    Sewerynek J, Wiktorska J, Nowak D, Lewinski A.
    Endocr Regul; 2000 Jun 10; 34(2):83-9. PubMed ID: 10911409
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P.
    Br J Surg; 2006 Oct 10; 93(10):1226-31. PubMed ID: 16838393
    [Abstract] [Full Text] [Related]

  • 13. Rising serum thyroxine levels and chorea in graves' disease.
    Leblicq C, Duval M, Carmant L, Van Vliet G, Alos N.
    Pediatrics; 2013 Feb 10; 131(2):e616-9. PubMed ID: 23296438
    [Abstract] [Full Text] [Related]

  • 14. Plasma selectin levels in patients with Graves' disease.
    Hara H, Sugita E, Sato R, Ban Y.
    Endocr J; 1996 Dec 10; 43(6):709-13. PubMed ID: 9075611
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs].
    Takamatsu J.
    Nihon Naibunpi Gakkai Zasshi; 1983 Mar 20; 59(3):295-303. PubMed ID: 6190686
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A follow-up study of 85 patients with Graves' disease in remission who developed undetectable serum thyroid-stimulating hormone concentrations using sensitive TSH assays.
    Nagai K, Tamai H, Mukuta T, Morita T, Matsubayashi S, Kuma K, Nakagawa T.
    Horm Res; 1991 Mar 20; 35(5):185-9. PubMed ID: 1802821
    [Abstract] [Full Text] [Related]

  • 19. Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.
    Clifton-Bligh P, Silverstein GE, Burke G.
    J Clin Endocrinol Metab; 1974 Apr 20; 38(4):531-8. PubMed ID: 4206830
    [No Abstract] [Full Text] [Related]

  • 20. Graves' disease associated with elevated serum thyroxine-binding globulin concentrations.
    Yabu Y, Amino N, Nakatani K, Ichihara K, Azukizawa M, Miyai K.
    J Clin Endocrinol Metab; 1980 Aug 20; 51(2):325-9. PubMed ID: 6772663
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.